Atai stock forecast.
The company's stock is trading at about 20 cents per share as of Oct. 24. Cybin Inc . ( CYBN) Cybin, a Canadian psychedelic drug developer that produces treatments for depression, anxiety and ...
Stock Price Forecast. The 1 analysts offering 12-month price forecasts for Bird Global Inc have a median target of 10.00, with a high estimate of 10.00 and a low estimate of 10.00. The median ...Some better-ranked stocks in the broader Medical space are Select Medical Holdings Corporation SEM, HCA Healthcare, Inc. HCA and Atai Life Sciences N.V. ATAI, each carrying a Zacks Rank #2 (Buy ...May 25, 2023 · These forecasts range from $9 to $20, indicating a considerable increase compared to its previous closing price of $1.88. Over the past 12 months, ATAI’s stock has witnessed a remarkable growth ... 25. 10. 2023. ... ... Atai in early October, with a price target of $20. Its closing price on Oct. 24 was $1.23. The very same week, Atai announced it had ...
atai Life Sciences N.V. Wallstraße 16 10179 Berlin, Germany Statutory Seat AmsterdamATAI - ATAI Life Sciences NV Stock quote - CNNMoney.com Markets Tech Media Success Video ATAI Life Sciences NV (NASDAQ:ATAI) 1.07 Delayed Data As of 3:58pm ET -0.055 / -4.91% Today’s... Find the latest CXApp Inc. (CXAI) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Performance Outlook. Short Term. 2W - 6W. Mid Term ...
ATAI Life Sciences N.V., a clinical-stage biopharmaceutical company, engages in acquiring, incubating, and developing various therapeutics to treat depression, anxiety, addiction, and other mental health disorders. Its principal clinical programs include RL-007, a pro-cognitive neuromodulator for cognitive impairment associated with ...
ATAI Stock Price | ATAI Life Sciences N.V. Stock Quote (U.S ...ATAI Life Sciences. ATAI Life Sciences NV is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. Its product candidates include COMP360/Psilocybin therapy, PCN-101/R-ketamine, RL-007/Compound, DMX-1002/Ibogaine, GRX-917/Deuterated etifoxine, VLS-01/DMT, EMP-01/MDMA derivative, RLS-01 ...111.91%. Get the latest ATAI Life Sciences NV (ATAI) real-time quote, historical performance, charts, and other financial information to help you make more informed …Web(See ATAI stock forecast on TipRanks) SomaLogic . The next Wood pick we’ll look at is a protein biomarker discovery and clinical diagnostics company. SomaLogic operates in what is known as the ...
Request a new password. showRSS is an internet tool that lets you keep track of your favorite TV shows.
Discover historical prices for ATAI stock on Yahoo Finance. View daily, weekly or monthly format back to when Atai Life Sciences N.V. stock was issued.
Stock Price Forecast. The 10 analysts offering 12-month price forecasts for Super Micro Computer Inc have a median target of 397.00, with a high estimate of 500.00 and a low estimate of 240.00 ...Notable forecast changes Current forecast: November 7, 2023; previous forecast: October 11, 2023 2023 2024 OPEC surplus crude oil production capacity (million barrels per day) 3.7 4.3 Previous forecast 4.1 4.9 Percentage change -10.0% -12.0% U.S. coal power demand (million short tons) 384 356 Previous forecast 373 342Nov 17, 2023 · According to the issued ratings of 1 analysts in the last year, the consensus rating for Arcadia Biosciences stock is Buy based on the current 1 buy rating for RKDA. The average twelve-month price prediction for Arcadia Biosciences is $15.00 with a high price target of $20.00 and a low price target of $10.00. Learn more on RKDA's analyst rating ... 35,390.15 +117.12(+0.33%) Nasdaq -15.00(-0.11%) Russell 2000 1,807.50 +11.96(+0.67%) Crude Oil 75.54 -1.56(-2.02%) Gold 2,003.00 +10.20(+0.51%) Atai Life Sciences N.V. …WebRPHM. Reneo Pharmaceuticals Inc. 6.04. +0.10. +1.68%. Get ATAI Life Sciences NV (ATAI:NASDAQ) real-time stock quotes, news, price and financial information from CNBC.
The team, led by chief investment officer Mike Wilson, agrees that there are clouds on the horizon over the near-term namely because earnings forecasts are down, economic data is weaker, and the ...According to the issued ratings of 1 analysts in the last year, the consensus rating for Arcadia Biosciences stock is Buy based on the current 1 buy rating for RKDA. The average twelve-month price prediction for Arcadia Biosciences is $15.00 with a high price target of $20.00 and a low price target of $10.00. Learn more on RKDA's analyst rating ...View the real-time ATAI price chart on Robinhood and decide if you want to buy or sell commission-free. Other fees such as trading (non-commission) fees, ...Complete ATAI Life Sciences N.V. stock information by Barron's. View real-time ATAI stock price and news, along with industry-best analysis.U.S. Television Show Ratings Ranking. Ranking is based on ratings data as of Monday, November 20, 2023. The audience figures are derived from the latest Nielsen daily, weekly, or monthly P2+ program audience averages, whichever is the most recently available within the past seven-day window.
atai is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. atai was founded in 2018 as a response to the significant unmet need and lack of ...43.55. -2.16%. 5.29M. Find the latest ATAI Life Sciences BV (ATAI) stock forecast, 12-month price target, predictions and analyst recommendations.Web
ATAI Life Sciences NV Stock Forecast. Is ATAI Life Sciences NV Stock Undervalued? The current ATAI Life Sciences NV [ ATAI] share price is $1.06. The Score for ATAI is 20, which is 60% below its historic median score of 50, and infers higher risk than normal. ATAI is currently trading in the 10-20% percentile range relative to its historical ...30. 8. 2022. ... Wall Street's 12-month median price forecast for ATAI stock stands at $24.50. Compass Pathways (CMPS). magic mushrooms representing champion ...3 Wall Street research analysts have issued twelve-month target prices for Trulieve Cannabis' stock. Their TCNNF share price targets range from $6.00 to $132.00. On average, they anticipate the company's stock price to reach $42.92 in the next year. This suggests a possible upside of 693.3% from the stock's current price.Find the latest TeraWulf Inc. (WULF) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Performance Outlook. Short Term. 2W - 6W. Mid ...3 Wall Street research analysts have issued twelve-month target prices for Trulieve Cannabis' stock. Their TCNNF share price targets range from $6.00 to $132.00. On average, they anticipate the company's stock price to reach $42.92 in the next year. This suggests a possible upside of 693.3% from the stock's current price.View a financial market summary for ATAI including stock price quote, trading volume, volatility, options volume, statistics, and other important company ...
ATAI stock closed at $1.76 and is up $0.10 during pre-market trading. Pre-market tends to be more volatile due to significantly lower volume as most investors only trade between standard trading hours. ATAI has a strong overall score of 70 meaning the stock holds a better value than 70% of stocks at its current price.
Price target. 13.80 0.00 0.00%. The 5 analysts offering 1 year price forecasts for ATAI have a max estimate of — and a min estimate of —.
Find real-time CRM - Salesforce Inc stock quotes, company profile, news and forecasts from CNN Business.Find the latest ATAI Life Sciences N.V. ATAI analyst stock forecast, price target, and recommendation trends with in-depth analysis from research reports. Date Range. investment rating.November 30, 2023. EPS forecast (this quarter) -$1.25. Annual revenue (last year) $244.7M. Annual profit (last year) -$358.7M. Net profit margin.Jul 14, 2021 · If you want to read our detailed analysis of these stocks, go directly to the 10 Best Psychedelic Stocks to Buy Now. 5. Cybin Inc. (OTC: CLXPF) Cybin Inc. (OTC: CLXPF) stock has returned more than ... Nov 29, 2023 · Atai Life Sciences Stock Price, News & Analysis (NASDAQ:ATAI) $1.10 +0.01 (+0.92%) (As of 11/24/2023 ET) Compare Today's Range $1.08 $1.12 50-Day Range $1.06 $1.52 52-Week Range $1.05 $3.65 Volume 272,978 shs Average Volume 997,775 shs Market Capitalization $182.61 million P/E Ratio N/A Dividend Yield N/A Price Target $12.80 Great weather can motivate you to get out of the house, while inclement weather can make you feel lethargic. When the weather’s great we want to be outside enjoying it. For the best regional weather forecasts check out AccuWeather.24. 3. 2023. ... ... predictions of future events. Although we believe that the ... Total stockholders' equity attributable to ATAI Life Sciences N.V. stockholders ...ATAI Life Sciences NV Follow Share $1.11 Nov 22, 2:08:38 PM GMT-5 · USD · NASDAQ · Disclaimer search Compare to Cybin Inc $0.46 CYBN2.61% Compass Pathways PLC $6.00 CMPS2.92% Mind Medicine... View atai Life Sciences NV ATAI investment & stock information. Get the latest atai Life Sciences NV ATAI detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.
ATAI - ATAI Life Sciences NV Stock quote - CNNMoney.com Markets Tech Media Success Video ATAI Life Sciences NV (NASDAQ:ATAI) 1.07 Delayed Data As of 3:58pm ET -0.055 / -4.91% Today’s... CLLS Stock 12 Months Forecast. $6.33. (116.04% Upside) Based on 4 Wall Street analysts offering 12 month price targets for Cellectis SA in the last 3 months. The average price target is $6.33 with a high forecast of $10.00 and a low forecast of $3.00. The average price target represents a 116.04% change from the last price of $2.93. According to the National Snow & Ice Data Center, blizzard prediction relies on modeling weather systems, as well as predicting temperatures. The heavy snowfall that blizzards create can be hard to predict in advance.ATAI Stock 12 Months Forecast. $14.00. (960.61% Upside) Based on 4 Wall Street analysts offering 12 month price targets for ATAI Life Sciences in the last 3 months. The average price target is $14.00 with a high forecast of $20.00 and a low forecast of $11.00. The average price target represents a 960.61% change from the last price of $1.32. Instagram:https://instagram. usaa have pet insurancehow can i buy hong kong stockshow to learn to be a day tradernyse nss STRO Stock 12 Months Forecast. Based on 6 Wall Street analysts offering 12 month price targets for Sutro Biopharma in the last 3 months. The average price target is $13.40 with a high forecast of $17.00 and a low forecast of $10.00. The average price target represents a 396.30% change from the last price of $2.70.Track ATAI Life Sciences N.V. (ATAI) Stock Price, Quote, latest community messages, chart, news and other stock related information. new found gold stockrobinhood alternatives for non us citizens The highest rated platform for investors in the world! TipRanks is a comprehensive research tool that helps investors make better, data-driven investment decisions. TipRanks stock market research and analysis, lets you see the track record and measured performance of any analyst or blogger, so you know who to trust! madrigal pharmaceuticals inc Nov 30, 2023 · According to the issued ratings of 4 analysts in the last year, the consensus rating for Atai Life Sciences stock is Buy based on the current 4 buy ratings for ATAI. The average twelve-month price prediction for Atai Life Sciences is $12.80 with a high price target of $20.00 and a low price target of $9.00. Learn more on ATAI's analyst rating ... NL0015000DX5. ATAI Life Sciences NV is a clinical-stage biopharmaceutical company. It engages in the treatment of mental health disorders. The company was founded by Christian Angermayer, Florian Brand, Srinivas Rao and Lars Christian Wilde in June 2018 and is headquartered in Berlin, Germany. Show more. Stock Price Forecast. The 10 analysts offering 12-month price forecasts for Super Micro Computer Inc have a median target of 397.00, with a high estimate of 500.00 and a low estimate of 240.00 ...